1
|
Zhang W, Yang J, Hao M, Zhou X, Sun K, Yang L, Wang B, Peng H, Yu Y, You Q, Li H, Qin S. GB05, a safe and effective IFNα1b inhalation solution for treating respiratory syncytial virus infection. Int J Pharm 2025; 673:125426. [PMID: 40037489 DOI: 10.1016/j.ijpharm.2025.125426] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2024] [Revised: 02/17/2025] [Accepted: 02/28/2025] [Indexed: 03/06/2025]
Abstract
Human respiratory syncytial virus (HRSV) infection is linked to significant morbidity and mortality in infants and young children worldwide, yet no effective treatment is available. Interferon α (IFNα), a major subtype among the IFN family, has demonstrated antiviral effects by activating the human immune system. Aerosol inhalation is a way of IFN administration that can enhance efficacy while decreasing serum IFNα concentrations and systemic exposure, thereby minimizing the risk of systemic toxicity. However, at present, human interferon α1b (IFNα1b) injection solution is used off-label for inhalation, raising safety concerns for infants. Additionally, natural IFNα1b contains a free sulfhydryl group from cysteine residue, increasing the risk of structural instability. Human serum albumin (HSA), an excipient in IFNα1b formulations, may pose safety risks to infants. To address these concerns, we developed GB05-human IFNα1b inhalation solution with optimized molecular design, expression system and formulation. First, GB05 protein was expressed in the periplasmic space to achieve easier purification. GB05 was engineered with a C86S mutation to prevent the formation of intermolecular disulfide bonds. Furthermore, GB05 was formulated according to regulations for inhalation solution, with a minimal HSA of 0.1 %, to ensure safety while preserving biological activity and stability. Plasma concentrations of GB05 following nebulization in cynomolgus macaques were significantly lower than those in the lungs, suggesting a reduced risk of systemic adverse events. Finally, GB05 showed good efficacy against HRSV infection in vitro and in vivo. In summary, GB05 is the first reported IFN inhalation solution manufactured in compliance with regulatory standards, to our knowledge, exhibiting safety and efficacy due to effectively local delivery. GB05 will fill the gap in the treatment of HRSV infection.
Collapse
Affiliation(s)
- Wenjun Zhang
- Centre for Research and Development, Kexing Biopharm Co., Ltd, Shenzhen 518057, China
| | - Jingan Yang
- Centre for Research and Development, Kexing Biopharm Co., Ltd, Shenzhen 518057, China
| | - Meiqi Hao
- Centre for Research and Development, Kexing Biopharm Co., Ltd, Shenzhen 518057, China
| | - Xinrong Zhou
- Centre for Research and Development, Kexing Biopharm Co., Ltd, Shenzhen 518057, China
| | - Kaiqing Sun
- Centre for Research and Development, Kexing Biopharm Co., Ltd, Shenzhen 518057, China
| | - Lijun Yang
- Centre for Research and Development, Kexing Biopharm Co., Ltd, Shenzhen 518057, China
| | - Bo Wang
- Centre for Research and Development, Kexing Biopharm Co., Ltd, Shenzhen 518057, China
| | - Hengxin Peng
- Centre for Research and Development, Kexing Biopharm Co., Ltd, Shenzhen 518057, China
| | - Yi Yu
- Centre for Research and Development, Kexing Biopharm Co., Ltd, Shenzhen 518057, China
| | - Qiongying You
- Centre for Research and Development, Kexing Biopharm Co., Ltd, Shenzhen 518057, China
| | - Huiming Li
- Centre for Research and Development, Kexing Biopharm Co., Ltd, Shenzhen 518057, China
| | - Suofu Qin
- Centre for Research and Development, Kexing Biopharm Co., Ltd, Shenzhen 518057, China.
| |
Collapse
|
2
|
Kouokam JC, Speer RM, Meaza I, Toyoda JH, Lu H, Wise JP. Transcriptomic analysis reveals particulate hexavalent chromium regulates key inflammatory pathways in human lung fibroblasts as a possible mechanism of carcinogenesis. Toxicol Appl Pharmacol 2024; 485:116889. [PMID: 38479592 PMCID: PMC11069317 DOI: 10.1016/j.taap.2024.116889] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2023] [Revised: 03/04/2024] [Accepted: 03/07/2024] [Indexed: 03/22/2024]
Abstract
Hexavalent chromium [Cr(VI)] is considered a major environmental health concern and lung carcinogen. However, the exact mechanism by which Cr(VI) causes lung cancer in humans remains unclear. Since several reports have demonstrated a role for inflammation in Cr(VI) toxicity, the present study aimed to apply transcriptomics to examine the global mRNA expression in human lung fibroblasts after acute (24 h) or prolonged (72 and 120 h) exposure to 0.1, 0.2 and 0.3 μg/cm2 zinc chromate, with a particular emphasis on inflammatory pathways. The results showed Cr(VI) affected the expression of multiple genes and these effects varied according to Cr(VI) concentration and exposure time. Bioinformatic analysis of RNA-Seq data based on the Gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) and MetaCore databases revealed multiple inflammatory pathways were affected by Cr(VI) treatment. qRT-PCR data corroborated RNA-Seq findings. This study showed for the first time that Cr(VI) regulates key inflammatory pathways in human lung fibroblasts, providing novel insights into the mechanisms by which Cr(VI) causes lung cancer.
Collapse
Affiliation(s)
- J Calvin Kouokam
- Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, 500 S Preston St, Rm, 1422 Louisville, KY, USA.
| | - Rachel M Speer
- Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, 500 S Preston St, Rm, 1422 Louisville, KY, USA; Current address: Department of Pharmaceutical Sciences, University of New Mexico, Albuquerque, NM 87131, USA
| | - Idoia Meaza
- Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, 500 S Preston St, Rm, 1422 Louisville, KY, USA
| | - Jennifer H Toyoda
- Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, 500 S Preston St, Rm, 1422 Louisville, KY, USA
| | - Haiyan Lu
- Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, 500 S Preston St, Rm, 1422 Louisville, KY, USA
| | - John Pierce Wise
- Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, 500 S Preston St, Rm, 1422 Louisville, KY, USA
| |
Collapse
|
3
|
Abd Elnabi MK, Elkaliny NE, Elyazied MM, Azab SH, Elkhalifa SA, Elmasry S, Mouhamed MS, Shalamesh EM, Alhorieny NA, Abd Elaty AE, Elgendy IM, Etman AE, Saad KE, Tsigkou K, Ali SS, Kornaros M, Mahmoud YAG. Toxicity of Heavy Metals and Recent Advances in Their Removal: A Review. TOXICS 2023; 11:580. [PMID: 37505546 PMCID: PMC10384455 DOI: 10.3390/toxics11070580] [Citation(s) in RCA: 87] [Impact Index Per Article: 43.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/28/2023] [Revised: 06/14/2023] [Accepted: 06/24/2023] [Indexed: 07/29/2023]
Abstract
Natural and anthropogenic sources of metals in the ecosystem are perpetually increasing; consequently, heavy metal (HM) accumulation has become a major environmental concern. Human exposure to HMs has increased dramatically due to the industrial activities of the 20th century. Mercury, arsenic lead, chrome, and cadmium have been the most prevalent HMs that have caused human toxicity. Poisonings can be acute or chronic following exposure via water, air, or food. The bioaccumulation of these HMs results in a variety of toxic effects on various tissues and organs. Comparing the mechanisms of action reveals that these metals induce toxicity via similar pathways, including the production of reactive oxygen species, the inactivation of enzymes, and oxidative stress. The conventional techniques employed for the elimination of HMs are deemed inadequate when the HM concentration is less than 100 mg/L. In addition, these methods exhibit certain limitations, including the production of secondary pollutants, a high demand for energy and chemicals, and reduced cost-effectiveness. As a result, the employment of microbial bioremediation for the purpose of HM detoxification has emerged as a viable solution, given that microorganisms, including fungi and bacteria, exhibit superior biosorption and bio-accumulation capabilities. This review deals with HM uptake and toxicity mechanisms associated with HMs, and will increase our knowledge on their toxic effects on the body organs, leading to better management of metal poisoning. This review aims to enhance comprehension and offer sources for the judicious selection of microbial remediation technology for the detoxification of HMs. Microbial-based solutions that are sustainable could potentially offer crucial and cost-effective methods for reducing the toxicity of HMs.
Collapse
Affiliation(s)
- Manar K. Abd Elnabi
- Botany Department, Faculty of Science, Tanta University, Tanta 31527, Egypt; (M.K.A.E.); (N.E.E.); (M.M.E.); (S.H.A.); (S.A.E.); (M.S.M.); (E.M.S.); (N.A.A.); (A.E.A.E.); (I.M.E.); (A.E.E.); (K.E.S.); (Y.A.-G.M.)
- Biotechnology Program, Institute of Basic and Applied Science (BAS), Egypt-Japan University of Science and Technology, New Borg El-Arab City 21934, Egypt
| | - Nehal E. Elkaliny
- Botany Department, Faculty of Science, Tanta University, Tanta 31527, Egypt; (M.K.A.E.); (N.E.E.); (M.M.E.); (S.H.A.); (S.A.E.); (M.S.M.); (E.M.S.); (N.A.A.); (A.E.A.E.); (I.M.E.); (A.E.E.); (K.E.S.); (Y.A.-G.M.)
| | - Maha M. Elyazied
- Botany Department, Faculty of Science, Tanta University, Tanta 31527, Egypt; (M.K.A.E.); (N.E.E.); (M.M.E.); (S.H.A.); (S.A.E.); (M.S.M.); (E.M.S.); (N.A.A.); (A.E.A.E.); (I.M.E.); (A.E.E.); (K.E.S.); (Y.A.-G.M.)
| | - Shimaa H. Azab
- Botany Department, Faculty of Science, Tanta University, Tanta 31527, Egypt; (M.K.A.E.); (N.E.E.); (M.M.E.); (S.H.A.); (S.A.E.); (M.S.M.); (E.M.S.); (N.A.A.); (A.E.A.E.); (I.M.E.); (A.E.E.); (K.E.S.); (Y.A.-G.M.)
| | - Shawky A. Elkhalifa
- Botany Department, Faculty of Science, Tanta University, Tanta 31527, Egypt; (M.K.A.E.); (N.E.E.); (M.M.E.); (S.H.A.); (S.A.E.); (M.S.M.); (E.M.S.); (N.A.A.); (A.E.A.E.); (I.M.E.); (A.E.E.); (K.E.S.); (Y.A.-G.M.)
| | - Sohaila Elmasry
- Microbiology Department, Faculty of science, Damanhour University, Behaira 22514, Egypt;
| | - Moustafa S. Mouhamed
- Botany Department, Faculty of Science, Tanta University, Tanta 31527, Egypt; (M.K.A.E.); (N.E.E.); (M.M.E.); (S.H.A.); (S.A.E.); (M.S.M.); (E.M.S.); (N.A.A.); (A.E.A.E.); (I.M.E.); (A.E.E.); (K.E.S.); (Y.A.-G.M.)
| | - Ebrahim M. Shalamesh
- Botany Department, Faculty of Science, Tanta University, Tanta 31527, Egypt; (M.K.A.E.); (N.E.E.); (M.M.E.); (S.H.A.); (S.A.E.); (M.S.M.); (E.M.S.); (N.A.A.); (A.E.A.E.); (I.M.E.); (A.E.E.); (K.E.S.); (Y.A.-G.M.)
| | - Naira A. Alhorieny
- Botany Department, Faculty of Science, Tanta University, Tanta 31527, Egypt; (M.K.A.E.); (N.E.E.); (M.M.E.); (S.H.A.); (S.A.E.); (M.S.M.); (E.M.S.); (N.A.A.); (A.E.A.E.); (I.M.E.); (A.E.E.); (K.E.S.); (Y.A.-G.M.)
| | - Abeer E. Abd Elaty
- Botany Department, Faculty of Science, Tanta University, Tanta 31527, Egypt; (M.K.A.E.); (N.E.E.); (M.M.E.); (S.H.A.); (S.A.E.); (M.S.M.); (E.M.S.); (N.A.A.); (A.E.A.E.); (I.M.E.); (A.E.E.); (K.E.S.); (Y.A.-G.M.)
| | - Ibrahim M. Elgendy
- Botany Department, Faculty of Science, Tanta University, Tanta 31527, Egypt; (M.K.A.E.); (N.E.E.); (M.M.E.); (S.H.A.); (S.A.E.); (M.S.M.); (E.M.S.); (N.A.A.); (A.E.A.E.); (I.M.E.); (A.E.E.); (K.E.S.); (Y.A.-G.M.)
| | - Alaa E. Etman
- Botany Department, Faculty of Science, Tanta University, Tanta 31527, Egypt; (M.K.A.E.); (N.E.E.); (M.M.E.); (S.H.A.); (S.A.E.); (M.S.M.); (E.M.S.); (N.A.A.); (A.E.A.E.); (I.M.E.); (A.E.E.); (K.E.S.); (Y.A.-G.M.)
| | - Kholod E. Saad
- Botany Department, Faculty of Science, Tanta University, Tanta 31527, Egypt; (M.K.A.E.); (N.E.E.); (M.M.E.); (S.H.A.); (S.A.E.); (M.S.M.); (E.M.S.); (N.A.A.); (A.E.A.E.); (I.M.E.); (A.E.E.); (K.E.S.); (Y.A.-G.M.)
| | - Konstantina Tsigkou
- Department of Chemical Engineering, University of Patras, 1 Karatheodori str, 26504 Patras, Greece;
| | - Sameh S. Ali
- Botany Department, Faculty of Science, Tanta University, Tanta 31527, Egypt; (M.K.A.E.); (N.E.E.); (M.M.E.); (S.H.A.); (S.A.E.); (M.S.M.); (E.M.S.); (N.A.A.); (A.E.A.E.); (I.M.E.); (A.E.E.); (K.E.S.); (Y.A.-G.M.)
- Biofuels Institute, School of the Environment and Safety Engineering, Jiangsu University, Zhenjiang 212013, China
| | - Michael Kornaros
- Department of Chemical Engineering, University of Patras, 1 Karatheodori str, 26504 Patras, Greece;
| | - Yehia A.-G. Mahmoud
- Botany Department, Faculty of Science, Tanta University, Tanta 31527, Egypt; (M.K.A.E.); (N.E.E.); (M.M.E.); (S.H.A.); (S.A.E.); (M.S.M.); (E.M.S.); (N.A.A.); (A.E.A.E.); (I.M.E.); (A.E.E.); (K.E.S.); (Y.A.-G.M.)
| |
Collapse
|
4
|
Cuevas-Magaña MY, Vega-García CC, León-Contreras JC, Hernández-Pando R, Zazueta C, García-Niño WR. Ellagic acid ameliorates hexavalent chromium-induced renal toxicity by attenuating oxidative stress, suppressing TNF-α and protecting mitochondria. Toxicol Appl Pharmacol 2022; 454:116242. [PMID: 36108929 DOI: 10.1016/j.taap.2022.116242] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2022] [Revised: 08/29/2022] [Accepted: 09/08/2022] [Indexed: 11/18/2022]
Abstract
Nephrotoxicity is an important adverse effect of oxidative stress induced by hexavalent chromium [Cr(VI)]. The effect of ellagic acid, a dietary polyphenolic compound with potent antioxidant activity, was investigated in Cr(VI)-induced kidney injury. Six groups of male Wistar rats were treated intragastrically with vehicle or ellagic acid (15 and 30 mg/kg) for 10 days. On day 10, rats received saline or Cr(VI) (K2Cr2O7 15 mg/kg) subcutaneously. Cr(VI) significantly increased kidney weight, affected kidney function assessed by biomarkers in blood and urine (protein, creatinine and urea nitrogen), caused histological changes (tubular injury and glomerular capillary tuft damage), increased markers of oxidative stress and reduced the activity of antioxidant enzymes. In addition, Cr(VI) altered mitochondrial ultrastructure, impaired mitochondrial respiration, increased lipid peroxidation, and inhibited the function of mitochondrial enzymes. Pretreatment with ellagic acid (30 mg/kg) attenuated all the aforementioned alterations. Furthermore, we explored whether ellagic acid might regulate the tumor necrosis factor-alpha (TNF-α)/receptor-interacting protein kinase 3 (RIPK3) pathway, reducing Cr(VI)-induced tubular necrosis. Cr(VI) upregulated both TNF-α and RIPK3, but ellagic acid only decreased TNF-α levels, having no effect on RIPK3 content. Therefore, understanding the mechanisms through which Cr(VI) promotes necroptosis is crucial for future studies, in order to design strategies to mitigate kidney damage. In conclusion, ellagic acid attenuated Cr(VI)-induced renal alterations by preventing oxidative stress, supporting enzymatic activities, suppressing TNF-α, and preserving mitochondrial ultrastructure and function, most likely due to its antioxidant properties.
Collapse
Affiliation(s)
- Mayra Yael Cuevas-Magaña
- Department of Cardiovascular Biomedicine, National Institute of Cardiology "Ignacio Chávez", Mexico City 14080, Mexico
| | - Claudia Cecilia Vega-García
- Department of Biology of Reproduction, National Institute of Medical Sciences and Nutrition "Salvador Zubirán", Mexico City 14000, Mexico
| | - Juan Carlos León-Contreras
- Experimental Pathology Section. National Institute of Medical Sciences and Nutrition "Salvador Zubirán", Mexico City 14000, Mexico
| | - Rogelio Hernández-Pando
- Experimental Pathology Section. National Institute of Medical Sciences and Nutrition "Salvador Zubirán", Mexico City 14000, Mexico
| | - Cecilia Zazueta
- Department of Cardiovascular Biomedicine, National Institute of Cardiology "Ignacio Chávez", Mexico City 14080, Mexico
| | - Wylly Ramsés García-Niño
- Department of Cardiovascular Biomedicine, National Institute of Cardiology "Ignacio Chávez", Mexico City 14080, Mexico.
| |
Collapse
|